{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-011013","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2024-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.746955+00:00","generated_at":"2026-06-06T09:10:02.375077+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Corbus Pharmaceuticals updates investor presentation; no material changes disclosed","bullets":["Filed updated corporate presentation dated February 2, 2024, as Exhibit 99.1.","Presentation title slide only provided; no specific operational or financial updates included.","No new drug pipeline milestones, financial results, or strategic changes announced.","Routine disclosure under Regulation FD; presentation available on company website."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-011013","json":"https://secwatch.observer/filing/0000950170-24-011013.json","markdown":"https://secwatch.observer/filing/0000950170-24-011013.md","text":"https://secwatch.observer/filing/0000950170-24-011013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024011013/0000950170-24-011013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024011013/crbp-20240205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T09:10:02.375077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}